TITLE

ANABOLIC HORMONES IN HEART THERAPY

AUTHOR(S)
Haan, D.
PUB. DATE
September 1963
SOURCE
Angiology;Sep1963, Vol. 14 Issue 9, p449
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
1. On the basis of experimental and clinica studies with testosterone the extent to which anabolic hormones are able to influence metabolism and contractility of the heart, muscle is discussed; 4-hydroxy-17-alpha-methyl-testosterone (Oranabol) was used for trials in 97 patients suffering from various heart diseases. 2. Comparative investigations showed: (1) in one-quarter of the eases normalization of the tension time and expulsion time, pathological atrial sounds, and EKG alterations regressed; (2) hypoproteinemia was compensated in 8 of 11 patients, while serum electrolyte rallies did not change considerably; (3) blood pressure and pulse frequency were not influenced; (4) nearly always improvement of the general condition was seen; in 9 of 23 patients stenocardia regressed with regard to frequency and intensity; stronger increases in weight occurred only in pathological underweight conditions; (5) in 6 of 23 patients treated, symptoms of insufficiency regressed after treatment with 4-hydroxy-17alpha-methyl-testosterone. 3. According to the findings of the investigation it can be assumed that anabolic hormones are able to influence favorably the disturbed metabolism of the myocardium, and that the performance of contraction of the heart muscle can be improved to a certain extent; a useful substitution therapy of diseases of the heart muscle thus becomes possible.
ACCESSION #
16434363

 

Related Articles

  • Finasteride may prevent prostate cancer.  // American Journal of Health-System Pharmacy;8/1/2003, Vol. 60 Issue 15, p1511 

    Researchers found that finasteride, which inhibits the conversion of testosterone to the more potent dihydrotestosterone, can also prevent the development of cancer. Men who received finasteride 5 mg per day for seven years as part of the federally supported Prostate Cancer Prevention Trial had...

  • Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder. Abdallah, R. T.; Simon, J. A. // International Journal of Impotence Research;Sep2007, Vol. 19 Issue 5, p458 

    Disorders of sexual dysfunction occur in nearly half of women during their life, and hypoactive sexual desire disorder accounts for most of those complaints. Although the relationship between low endogenous testosterone levels and sexual desire disorders in women has not been empirically...

  • Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels. Vigen, Rebecca; O'Donnell, Colin I.; Barón, Anna E.; Grunwald, Gary K.; Maddox, Thomas M.; Bradley, Steven M.; Barqawi, Al; Woning, Glenn; Wierman, Margaret E.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael // JAMA: Journal of the American Medical Association;11/6/2013, Vol. 310 Issue 17, p1829 

    IMPORTANCE Rates of testosterone therapy are increasing and the effects of testosterone therapy on cardiovascular outcomes and mortality are unknown. A recent randomized clinical trial of testosterone therapy in men with a high prevalence of cardiovascular diseases was stopped prematurely due to...

  • Testosterone Trial Halted.  // JAMA: Journal of the American Medical Association;8/25/2010, Vol. 304 Issue 8, p846 

    The article reports on the decision of a data and safety monitoring board (DSMB) to stop the treatment phase of a clinical trial of testosterone therapy following the identification of adverse cardiovascular effects in the treatment group.

  • Circulation: Heart Failure.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article presents a review of literature stating that testosterone supplements may help stable heart failure patients to breathe easy and exercise without any further complications but it requires clinical trials for its validation.

  • Testosterone Use in Men With Sexual Dysfunction: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. Boloña, Enrique R.; Uraga, Maria V.; Haddad, Rudy M.; Tracz, Michal J.; Sideras, Kostandinos; Kennedy, Cassie C.; Caples, Sean M.; Erwin, Patricia J.; Montori, Victor M. // Mayo Clinic Proceedings;Jan2007, Vol. 82 Issue 1, p20 

    OBJECTIVE: To conduct a systematic review and meta-analysis of randomized placebo-controlled trials to measure the effect of testosterone use on sexual function in men with sexual dysfunction and varying testosterone levels. METHODS: Librarian-designed search strategies were used to search the...

  • Urologists should spearhead testosterone trials. Bankhead, Charles // Urology Times;10/1/2004, Vol. 32 Issue 14, p16 

    Focuses on the need for urologists to conduct clinical trials to define the safety and benefits of testosterone therapy in older men in the U.S. Lack of information about the efficacy of testosterone supplementation and replacement; Treatment of clinically hypogonadal men; Details on the...

  • Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men. Emmelot-Vonk, Marielle H.; Verhaar, Harald J. J.; Nakhai Pour, Hamid R.; Aleman, André; Lock, Tycho M. T. W.; Bosch, J. L. H. Ruud; Grobbee, Diederick E.; van der Schouw, Yvonne T. // JAMA: Journal of the American Medical Association;1/2/2008, Vol. 299 Issue 1, p39 

    This article presents the results of a clinical trial looking at the effect of testosterone supplementation in older men and its effect on functional mobility, cognitive function, bone density, body mass, lipid levels and quality of life. Decline in the hormone is associated with many aging...

  • Cancer fears stall trials for testosterone replacement. Bonetta, Laura // Nature Medicine;Jul2003, Vol. 9 Issue 7, p808 

    Reports that trials to evaluate testosterone replacement therapy for men are to remain on hold pending publication of a review by an independent panel of experts. Recommendations of the Institute Medicine task force due in November 2003; Design, safety and ethics of clinical trials; Concerns...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics